Cardiovascular Endocrinology and Metabolism

Cardiovascular Endocrinology and Metabolism

Theory and Practice of Cardiometabolic Medicine

1st Edition - September 1, 2022

Write a review

  • Editors: Andrew Krentz, Robert Chilton
  • Paperback ISBN: 9780323999915

Purchase options

Purchase options
Available for Pre-Order
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes. The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.

Key Features

  • Discusses the intersection between metabolic disorders and cardiovascular diseases
  • Provides a comprehensive understanding of the relevant pathophysiology of diseases as a basis for the evidence-based management of cardiometabolic disorders
  • Offers a comprehensive reference, ranging from basic science and pathophysiology to clinical diagnostics and management

Readership

Basic scientists working in translational endocrinology or cardiology, practicing endocrinologists and cardiologists

Table of Contents

  • Part 1. Basic science and pathophysiology
    1. Obesity and insulin resistance
    2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment
    3. Hypertension
    4. Lipid metabolism: role in atherogenesis
    5. Renal disease and cardiorenal interactions
    6. NAFLD/NASH and cardiovascular risk
    7. Heart failure
    8. Prothrombosis: association with cardiometabolic disease
    9. Inflammation, metabolism and cardiovascular disease
    10. Classic endocrine disorders: association with vascular disease

    Part 2. Clinical evaluation, lifestyle measures and therapeutic options
    11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease
    12. Obesity: pharmacological approaches to prevention and management
    13. Diabetes: evolution of multifactorial vascular risk reduction
    14. Diabetes CVOTS: design, interpretation and future directions
    15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection
    16: Hypertension: pharmacological and surgical management
    17. PCSK-9 inhibitors and other novel lipid-modifying drugs
    18. Recent therapeutic developments in heart failure
    19. Antiplatelet agents
    20. Progress in anticoagulant therapy
    21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow
    22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty

Product details

  • No. of pages: 300
  • Language: English
  • Copyright: © Academic Press 2022
  • Published: September 1, 2022
  • Imprint: Academic Press
  • Paperback ISBN: 9780323999915

About the Editors

Andrew Krentz

Andrew Krentz has four decades of clinical and translational research experience in metabolic, endocrine and related cardiovascular disorders. His expertise in the life sciences includes preclinical and early-phase clinical drug development; he has personally contributed translational medical innovations to endocrinology clinical practice. He is actively involved in projects focused on precision diagnostics and therapeutics, digital healthcare, and healthy longevity that bridge the academic-industry spaces. Beyond his expertise in diabetes and endocrinology, he is accredited as a clinical specialist by the European Society for Hypertension and is a member of the Medical, Scientific & Research Committee of Heart UK. He is President-Elect of the Vascular, Lipid & Metabolism section of the Royal Society of Medicine as well as being a member of the European Group for the Study of Insulin Resistance (EGIR) and the Diabetes & Cardiovascular Study Group of the European Association for the Study of Diabetes (EASD). He has authored more than 200 scientific publications and founded the journal Cardiovascular Endocrinology & Metabolism and serves as Editor-in-Chief.

Affiliations and Expertise

Visiting Professor, Institute of Cardiovascular and Metabolic Research, University of Reading, UK

Robert Chilton

Robert J. Chilton, DO, is a Clinical Professor of Medicine, Director of the Cardiac Catheterization Laboratory at University Hospital and the Audie L. Murphy VA Hospital, and Associate Program Director of the Interventional Cardiology Fellowship Program. A fellow of the American College of Cardiology, American College of Physicians, American College of Osteopathic Internists, and American Heart Association, Dr. Chilton also chairs the Electrophysiology Board Examination for the American Osteopathic Association and presides over the San Antonio chapters of both the Cardiovascular Society and American Heart Association. Over the past 20 years, Dr. Chilton has authored numerous articles, book chapters, abstracts, and presentations on cardiology. He has developed educational materials and has lectured widely, garnering several awards for his academic contributions, including 1994 Outstanding Teacher from the UT San Antonio.

Affiliations and Expertise

Professor, Department of Medicine, Division of Cardiology, University of Texas, San Antonio, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Cardiovascular Endocrinology and Metabolism"